Friedman H D, Sanderson S O, Stein C K, Shrimpton A, Gonchoroff N J, Zamkoff K W, Loughran T P
Pathology and Laboratory Medicine, VA Healthcare Network Upstate NY at Syracuse, 13210-2796, USA.
Ann Hematol. 1998 Jul-Aug;77(1-2):79-83. doi: 10.1007/s002770050417.
Human recombinant granulocyte colony-stimulating factor (G-CSF) has become a treatment of choice for neutropenia of diverse etiologies. We describe a 71-year-old man who, while receiving G-CSF for graft failure after peripheral blood stem cell transplant, developed dramatic extramedullary granulopoiesis that mimicked recurrent lymphoma.